Chlorofluorocarbon-free inhalers: Are we ready for the change?

European Respiratory Journal

Volumn 11, Issue 5, 1998, Pages 1006-1008

  Partridge, M R ^a   Woodcock, A A ^b   Sheffer, A L ^c   Wanner, A ^d   Rubinfeld, A ^e  

^a WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Airway diseases; Chlorofluorocarbons; Inhalers

Indexed keywords

CHLOROFLUOROCARBON;

AEROSOL; DRUG FORMULATION; DRUG SYNTHESIS; ENVIRONMENTAL PROTECTION; METERED DOSE INHALER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW;

CHLOROFLUOROCARBONS; ENVIRONMENTAL MONITORING; HUMANS; NEBULIZERS AND VAPORIZERS; RESPIRATORY TRACT DISEASES;

EID: 0031816191     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11051006     Document Type: Review

References (6)

1. Molina MJ, Rowland FS. Stratospheric sink for chlorofluoromethanes: chlorine-atom catalysed destruction of ozone. Nature 1974; 249: 810-814.
2. Farman JC, Gardiner BG, Shanklin JD. Large losses of total ozone in Antartica reveal seasonal CLOx/NOx/C interaction. Nature 1985; 315: 207-210.
3. Lloyd SA. Stratospheric ozone depletion. Lancet 1993; 342: 1156-1158.
4. Jeevan A, Kripke ML. Ozone depletion and the immune system. Lancet 1993; 342: 1159-1160.
5. Young AR. The biological effects of ozone depletion. Br J Clin Pract (Suppl) 1997; 89: 10-15.
6. United Nations Environment Programme Technology and Economic Assessment Panel of the Montreal Protocol on substances that deplete the ozone layer. Part III Update of the 1994 T.O.C. Aerosols Report and the M.D.I. Transition Strategy, TEAP 1996.